Literature DB >> 18006457

Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells.

Patrick Müller1, Andrey Kazakov, Alexander Semenov, Michael Böhm, Ulrich Laufs.   

Abstract

AIM: The regulation of angiogenesis in the hypertrophied overloaded heart is incompletely understood. Bone-marrow-derived progenitor cells have been shown to contribute to endothelial homeostasis, repair, and new blood vessel formation. We therefore studied the effects of pressure overload on angiogenesis and progenitor cells. METHODS AND
RESULTS: Pressure overload induced by transaortic constriction (TAC, C57/Bl6 mice, 360 microm for 35 days) increased left ventricular (LV) systolic pressure, the ratio of heart weight to tibia length, cardiomyocyte diameters, and cardiac apoptosis and fibrosis compared to sham-operated mice. In the TAC group, the number of cycling Ki67 pos cells increased from none to 0.1 +/- 0.02% in cardiomyocytes and from 0.17 +/- 0.02% to 0.65 +/- 0.1% in non-cardiomyocytes, P < 0.001. stem cell antigen 1(pos)/vascular endothelial growth factor receptor 2 pos endothelial progenitor cells (EPC) increased to 210 +/- 25% in the blood and to 196 +/- 21% in the bone marrow (P < 0.01). TAC upregulated cultured spleen-derived DiLDL pos/lectin pos EPC to 221 +/- 37%, P < 0.001. Cardiac hypertrophy and upregulation of EPC secondary to cardiac pressure overload were associated with increased extra-cardiac neoangiogenesis (54 +/- 12% increase, P < 0.05). In endothelial nitric oxide synthase double knockout mice, the upregulation of EPC by TAC was abolished. Maladaptive myocardial remodelling in TAC mice was characterized by a reduction of CD31 pos cells. In mice transplanted with green fluorescent protein pos bone marrow, TAC markedly increased myocardial bone marrow-derived CD31 pos cells from 2.37 +/- 0.4% to 7.76 +/- 1.5% and MEF2 pos cells from 1.8 +/- 0.4/mm2 to 20.5 +/- 5.3/mm2, P < 0.05.
CONCLUSION: Pressure-induced myocardial hypertrophy leads to upregulation of systemic EPCs, increased extra-cardiac angiogenesis, and upregulation of intra-myocardial bone marrow-derived endothelial and myocyte precursor cells. The data show that afterload-dependent regulation of bone marrow-derived progenitor cells contributes to angiogenesis in myocardial hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006457     DOI: 10.1093/cvr/cvm037

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  19 in total

1.  Apoptosis in severe, compensated pressure overload predominates in nonmyocytes and is related to the hypertrophy but not function.

Authors:  Ricardo J Gelpi; Misun Park; Shumin Gao; Sunil Dhar; Dorothy E Vatner; Stephen F Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

2.  BMPER regulates cardiomyocyte size and vessel density in vivo.

Authors:  Monte S Willis; Laura A Dyer; Rongqin Ren; Pamela Lockyer; Isabel Moreno-Miralles; Jonathan C Schisler; Cam Patterson
Journal:  Cardiovasc Pathol       Date:  2012-11-28       Impact factor: 2.185

3.  Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle.

Authors:  Gen Suzuki; Vijay Iyer; Thomas Cimato; John M Canty
Journal:  Circ Res       Date:  2008-12-18       Impact factor: 17.367

4.  Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension.

Authors:  Karen C Young; Eneida Torres; Konstantinos E Hatzistergos; Dorothy Hehre; Cleide Suguihara; Joshua M Hare
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

5.  Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study.

Authors:  Ramachandran S Vasan; Serkalem Demissie; Masayuki Kimura; L Adrienne Cupples; Charles White; Jeffrey P Gardner; Xiaogian Cao; Daniel Levy; Emelia J Benjamin; Abraham Aviv
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

6.  Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.

Authors:  S-L Puhl; A Kazakov; A Müller; P Fries; D R Wagner; M Böhm; C Maack; Y Devaux
Journal:  Br J Pharmacol       Date:  2015-11-16       Impact factor: 8.739

7.  Stromal cell derived factor-1α promotes C-Kit+ cardiac stem/progenitor cell quiescence through casein kinase 1α and GSK3β.

Authors:  Neviana Dimova; Marcin Wysoczynski; Gregg Rokosh
Journal:  Stem Cells       Date:  2014-02       Impact factor: 6.277

8.  Mineralocorticoid Receptor in Smooth Muscle Contributes to Pressure Overload-Induced Heart Failure.

Authors:  Seung Kyum Kim; Lauren A Biwer; M Elizabeth Moss; Joshua J Man; Mark J Aronovitz; Gregory L Martin; Francisco J Carrillo-Salinas; Ane M Salvador; Pilar Alcaide; Iris Z Jaffe
Journal:  Circ Heart Fail       Date:  2021-02-01       Impact factor: 8.790

9.  Increased mobilization of mesenchymal stem cells in patients with essential hypertension: the effect of left ventricular hypertrophy.

Authors:  Maria E Marketou; Fragiskos I Parthenakis; Athanasia Kalyva; Charalampos Pontikoglou; Spyros Maragkoudakis; Joanna E Kontaraki; Evangelos A Zacharis; Gregory Chlouverakis; Alexandros Patrianakos; Helen A Papadaki; Panos E Vardas
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-10-20       Impact factor: 3.738

10.  Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness.

Authors:  Maria E Marketou; Athanasia Kalyva; Fragiskos I Parthenakis; Charalampos Pontikoglou; Spyros Maragkoudakis; Joanna E Kontaraki; Gregory Chlouverakis; Evangelos A Zacharis; Alexandros Patrianakos; Helen A Papadaki; Panos E Vardas
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.